OTC Derivatives — In the Crosshairs of Regulatory Change, Part II
18 June 2009
Mayer Brown Legal Update
Over-the-counter (OTC) derivatives have drawn a heavy dose of politicians’ ire during the current financial downturn. In a previous update discussing regulatory developments facing the OTC derivatives market, we described a number of Congressional Committee bills and a framework outlined by the Secretary of the U.S. Department of the Treasury, upon which the Obama Administration expects Congress to build a new regulatory regime for OTC derivatives.